AVSF - Surge Therapeutics 2023, LLC — Form D/A
AVSF - Surge Therapeutics 2023, LLC of Boston, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2023-10-24. The offering totals $2.9M, of which $2.9M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-10-24
- Form: D/A
- Accession: 0001982296-23-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $2.9M
- Amount sold: $2.9M
- Minimum investment: $5K
- Investors: 207
- Date of first sale: 2023-06-09
- Security types: equity, fund interests
- Revenue range: $1 - $1,000,000
- SEC file number: 021-484977
Issuer
- Name: AVSF - Surge Therapeutics 2023, LLC
- CIK: 0001982296
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 70 Federal Street, Boston, MA, 02110
- Phone: 603-518-8112
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Michael Collins | Executive Officer | Del Mar, CA |
Other filings by this issuer (1)
More